APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artemisinin Derivatives

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Artemisinin Derivatives Market Outlook and Growth Opportunities 2026

27 December 2025190 pages

Choose your research edition.

Industry ResearchArtemisinin Derivatives Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Artemisinin Derivatives Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Artemisinin Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artemisinin Derivatives Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Artemisinin Derivatives Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Artemisinin Derivatives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Artemisinin Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Artemisinin Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artemisinin Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Artemisinin Derivatives market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Artemisinin Derivatives market include Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Shanghai Natural Bio-engineering, Sanofi, Kunming Pharmaceutical, Kerui Nanhai, Guilin Pharmaceutical, Guangxi Xiancaotang Pharmaceutical and Guangxi Xiancaotang, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Artemisinin Derivatives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artemisinin Derivatives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artemisinin Derivatives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artemisinin Derivatives market size, projected growth trends, production technologies, key applications, and end-use industries.

Artemisinin Derivatives Segment by Company

Kerui Nanhai Pharmaceutical

Shanghai Natural Bio-engineering Co

Shanghai Natural Bio-engineering

Sanofi

Kunming Pharmaceutical

Kerui Nanhai

Guilin Pharmaceutical

Guangxi Xiancaotang Pharmaceutical

Guangxi Xiancaotang

Novanat Bioresource

KPC Pharmaceuticals

Botanical Extracts EPZ Ltd

ArtemiFlow

Artemisinin Derivatives Segment by Type

Dihydroartemisinin

Artemisunate

Others

Artemisinin Derivatives Segment by Application

Malaria Treatment

Scientific Research

Others

Artemisinin Derivatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Artemisinin Derivatives status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Artemisinin Derivatives market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artemisinin Derivatives significant trends, drivers, influence factors in global and regions.

6. To analyze Artemisinin Derivatives competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artemisinin Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Artemisinin Derivatives market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artemisinin Derivatives industry.

Chapter 3: Detailed analysis of Artemisinin Derivatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Artemisinin Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Artemisinin Derivatives in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artemisinin Derivatives Industry Trends Table 2. Artemisinin Derivatives Industry Drivers Table 3. Artemisinin Derivatives Industry Opportunities and Challenges Table 4. Artemisinin Derivatives Industry Restraints Table 5. Global Artemisinin Derivatives Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artemisinin Derivatives Revenue Share by Company (2021-2026) Table 7. Global Artemisinin Derivatives Sales Volume by Company (t) & (2021-2026) Table 8. Global Artemisinin Derivatives Sales Volume Share by Company (2021-2026) Table 9. Global Artemisinin Derivatives Average Price (USD/t) of Company (2021-2026) Table 10. Global Artemisinin Derivatives Company Ranking, (2024-2026) & (USD Million) Table 11. Global Artemisinin Derivatives Key Company Manufacturing Base & Headquarters Table 12. Global Artemisinin Derivatives Company, Product Type & Application Table 13. Global Artemisinin Derivatives Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Artemisinin Derivatives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Dihydroartemisinin Table 18. Significant Companies of Artemisunate Table 19. Significant Companies of Others Table 20. Global Artemisinin Derivatives Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 21. Global Artemisinin Derivatives Sales Volume by Type (2021-2026) & (t) Table 22. Global Artemisinin Derivatives Sales Volume by Type (2027-2032) & (t) Table 23. Global Artemisinin Derivatives Sales Volume Share by Type (2021-2026) Table 24. Global Artemisinin Derivatives Sales Volume Share by Type (2027-2032) Table 25. Global Artemisinin Derivatives Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Artemisinin Derivatives Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Artemisinin Derivatives Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Artemisinin Derivatives Sales Value Share by Type (2021-2026) Table 29. Global Artemisinin Derivatives Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Malaria Treatment Table 31. Significant Companies of Scientific Research Table 32. Significant Companies of Others Table 33. Global Artemisinin Derivatives Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 34. Global Artemisinin Derivatives Sales Volume by Application (2021-2026) & (t) Table 35. Global Artemisinin Derivatives Sales Volume by Application (2027-2032) & (t) Table 36. Global Artemisinin Derivatives Sales Volume Share by Application (2021-2026) Table 37. Global Artemisinin Derivatives Sales Volume Share by Application (2027-2032) Table 38. Global Artemisinin Derivatives Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Artemisinin Derivatives Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Artemisinin Derivatives Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Artemisinin Derivatives Sales Value Share by Application (2021-2026) Table 42. Global Artemisinin Derivatives Sales Value Share by Application (2027-2032) Table 43. Global Artemisinin Derivatives Sales by Region: 2021 VS 2025 VS 2032 (t) Table 44. Global Artemisinin Derivatives Sales by Region (2021-2026) & (t) Table 45. Global Artemisinin Derivatives Sales Market Share by Region (2021-2026) Table 46. Global Artemisinin Derivatives Sales by Region (2027-2032) & (t) Table 47. Global Artemisinin Derivatives Sales Market Share by Region (2027-2032) Table 48. Global Artemisinin Derivatives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Artemisinin Derivatives Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Artemisinin Derivatives Sales Value Share by Region (2021-2026) Table 51. Global Artemisinin Derivatives Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Artemisinin Derivatives Sales Value Share by Region (2027-2032) Table 53. Global Artemisinin Derivatives Market Average Price (USD/t) by Region (2021-2026) Table 54. Global Artemisinin Derivatives Market Average Price (USD/t) by Region (2027-2032) Table 55. Global Artemisinin Derivatives Sales by Country: 2021 VS 2025 VS 2032 (t) Table 56. Global Artemisinin Derivatives Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Artemisinin Derivatives Sales by Country (2021-2026) & (t) Table 58. Global Artemisinin Derivatives Sales Market Share by Country (2021-2026) Table 59. Global Artemisinin Derivatives Sales by Country (2027-2032) & (t) Table 60. Global Artemisinin Derivatives Sales Market Share by Country (2027-2032) Table 61. Global Artemisinin Derivatives Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Artemisinin Derivatives Sales Value Market Share by Country (2021-2026) Table 63. Global Artemisinin Derivatives Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Artemisinin Derivatives Sales Value Market Share by Country (2027-2032) Table 65. Kerui Nanhai Pharmaceutical Company Information Table 66. Kerui Nanhai Pharmaceutical Business Overview Table 67. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 68. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product Portfolio Table 69. Kerui Nanhai Pharmaceutical Recent Development Table 70. Shanghai Natural Bio-engineering Co Company Information Table 71. Shanghai Natural Bio-engineering Co Business Overview Table 72. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product Portfolio Table 74. Shanghai Natural Bio-engineering Co Recent Development Table 75. Shanghai Natural Bio-engineering Company Information Table 76. Shanghai Natural Bio-engineering Business Overview Table 77. Shanghai Natural Bio-engineering Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. Shanghai Natural Bio-engineering Artemisinin Derivatives Product Portfolio Table 79. Shanghai Natural Bio-engineering Recent Development Table 80. Sanofi Company Information Table 81. Sanofi Business Overview Table 82. Sanofi Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. Sanofi Artemisinin Derivatives Product Portfolio Table 84. Sanofi Recent Development Table 85. Kunming Pharmaceutical Company Information Table 86. Kunming Pharmaceutical Business Overview Table 87. Kunming Pharmaceutical Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. Kunming Pharmaceutical Artemisinin Derivatives Product Portfolio Table 89. Kunming Pharmaceutical Recent Development Table 90. Kerui Nanhai Company Information Table 91. Kerui Nanhai Business Overview Table 92. Kerui Nanhai Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. Kerui Nanhai Artemisinin Derivatives Product Portfolio Table 94. Kerui Nanhai Recent Development Table 95. Guilin Pharmaceutical Company Information Table 96. Guilin Pharmaceutical Business Overview Table 97. Guilin Pharmaceutical Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. Guilin Pharmaceutical Artemisinin Derivatives Product Portfolio Table 99. Guilin Pharmaceutical Recent Development Table 100. Guangxi Xiancaotang Pharmaceutical Company Information Table 101. Guangxi Xiancaotang Pharmaceutical Business Overview Table 102. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 103. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product Portfolio Table 104. Guangxi Xiancaotang Pharmaceutical Recent Development Table 105. Guangxi Xiancaotang Company Information Table 106. Guangxi Xiancaotang Business Overview Table 107. Guangxi Xiancaotang Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 108. Guangxi Xiancaotang Artemisinin Derivatives Product Portfolio Table 109. Guangxi Xiancaotang Recent Development Table 110. Novanat Bioresource Company Information Table 111. Novanat Bioresource Business Overview Table 112. Novanat Bioresource Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 113. Novanat Bioresource Artemisinin Derivatives Product Portfolio Table 114. Novanat Bioresource Recent Development Table 115. KPC Pharmaceuticals Company Information Table 116. KPC Pharmaceuticals Business Overview Table 117. KPC Pharmaceuticals Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 118. KPC Pharmaceuticals Artemisinin Derivatives Product Portfolio Table 119. KPC Pharmaceuticals Recent Development Table 120. Botanical Extracts EPZ Ltd Company Information Table 121. Botanical Extracts EPZ Ltd Business Overview Table 122. Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 123. Botanical Extracts EPZ Ltd Artemisinin Derivatives Product Portfolio Table 124. Botanical Extracts EPZ Ltd Recent Development Table 125. ArtemiFlow Company Information Table 126. ArtemiFlow Business Overview Table 127. ArtemiFlow Artemisinin Derivatives Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 128. ArtemiFlow Artemisinin Derivatives Product Portfolio Table 129. ArtemiFlow Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Artemisinin Derivatives Distributors List Table 133. Artemisinin Derivatives Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Artemisinin Derivatives Product Image Figure 2. Global Artemisinin Derivatives Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artemisinin Derivatives Sales Value (2021-2032) & (US$ Million) Figure 4. Global Artemisinin Derivatives Sales (2021-2032) & (t) Figure 5. Global Artemisinin Derivatives Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Artemisinin Derivatives Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Dihydroartemisinin Image Figure 10. Artemisunate Image Figure 11. Others Image Figure 12. Global Artemisinin Derivatives Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global Artemisinin Derivatives Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Artemisinin Derivatives Sales Volume Share by Type (2021-2032) Figure 15. Global Artemisinin Derivatives Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Artemisinin Derivatives Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Artemisinin Derivatives Sales Value Share by Type (2021-2032) Figure 18. Malaria Treatment Image Figure 19. Scientific Research Image Figure 20. Others Image Figure 21. Global Artemisinin Derivatives Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global Artemisinin Derivatives Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Artemisinin Derivatives Sales Volume Share by Application (2021-2032) Figure 24. Global Artemisinin Derivatives Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Artemisinin Derivatives Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Artemisinin Derivatives Sales Value Share by Application (2021-2032) Figure 27. Global Artemisinin Derivatives Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 28. Global Artemisinin Derivatives Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Artemisinin Derivatives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Artemisinin Derivatives Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Artemisinin Derivatives Sales Value (2021-2032) & (US$ Million) Figure 32. North America Artemisinin Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Artemisinin Derivatives Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Artemisinin Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Artemisinin Derivatives Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Artemisinin Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Artemisinin Derivatives Sales Value (2021-2032) & (US$ Million) Figure 38. South America Artemisinin Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Artemisinin Derivatives Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Artemisinin Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Artemisinin Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Artemisinin Derivatives Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Artemisinin Derivatives Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Dihydroartemisinin
  • Artemisunate
  • Others
Applications
  • Malaria Treatment
  • Scientific Research
  • Others
Companies covered
  • Kerui Nanhai Pharmaceutical
  • Shanghai Natural Bio-engineering Co
  • Shanghai Natural Bio-engineering
  • Sanofi
  • Kunming Pharmaceutical
  • Kerui Nanhai
  • Guilin Pharmaceutical
  • Guangxi Xiancaotang Pharmaceutical
  • Guangxi Xiancaotang
  • Novanat Bioresource
  • KPC Pharmaceuticals
  • Botanical Extracts EPZ Ltd
  • ArtemiFlow

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Artemisinin Derivatives Sales Value (2021-2032)
  4. 1.2.2 Global Artemisinin Derivatives Sales Volume (2021-2032)
  5. 1.2.3 Global Artemisinin Derivatives Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Artemisinin Derivatives Market Dynamics
  1. 2.1 Artemisinin Derivatives Industry Trends
  2. 2.2 Artemisinin Derivatives Industry Drivers
  3. 2.3 Artemisinin Derivatives Industry Opportunities and Challenges
  4. 2.4 Artemisinin Derivatives Industry Restraints
3 Artemisinin Derivatives Market by Company
  1. 3.1 Global Artemisinin Derivatives Company Revenue Ranking in 2025
  2. 3.2 Global Artemisinin Derivatives Revenue by Company (2021-2026)
  3. 3.3 Global Artemisinin Derivatives Sales Volume by Company (2021-2026)
  4. 3.4 Global Artemisinin Derivatives Average Price by Company (2021-2026)
  5. 3.5 Global Artemisinin Derivatives Company Ranking (2024-2026)
  6. 3.6 Global Artemisinin Derivatives Company Manufacturing Base and Headquarters
  7. 3.7 Global Artemisinin Derivatives Company Product Type and Application
  8. 3.8 Global Artemisinin Derivatives Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Artemisinin Derivatives Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Artemisinin Derivatives Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Artemisinin Derivatives Market by Type
  1. 4.1 Artemisinin Derivatives Type Introduction
  2. 4.1.1 Dihydroartemisinin
  3. 4.1.2 Artemisunate
  4. 4.1.3 Others
  5. 4.2 Global Artemisinin Derivatives Sales Volume by Type
  6. 4.2.1 Global Artemisinin Derivatives Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Artemisinin Derivatives Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Artemisinin Derivatives Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Artemisinin Derivatives Sales Value by Type
  10. 4.3.1 Global Artemisinin Derivatives Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Artemisinin Derivatives Sales Value by Type (2021-2032)
  12. 4.3.3 Global Artemisinin Derivatives Sales Value Share by Type (2021-2032)
5 Artemisinin Derivatives Market by Application
  1. 5.1 Artemisinin Derivatives Application Introduction
  2. 5.1.1 Malaria Treatment
  3. 5.1.2 Scientific Research
  4. 5.1.3 Others
  5. 5.2 Global Artemisinin Derivatives Sales Volume by Application
  6. 5.2.1 Global Artemisinin Derivatives Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Artemisinin Derivatives Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Artemisinin Derivatives Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Artemisinin Derivatives Sales Value by Application
  10. 5.3.1 Global Artemisinin Derivatives Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Artemisinin Derivatives Sales Value by Application (2021-2032)
  12. 5.3.3 Global Artemisinin Derivatives Sales Value Share by Application (2021-2032)
6 Artemisinin Derivatives Regional Sales and Value Analysis
  1. 6.1 Global Artemisinin Derivatives Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artemisinin Derivatives Sales by Region (2021-2032)
  3. 6.2.1 Global Artemisinin Derivatives Sales by Region: 2021-2026
  4. 6.2.2 Global Artemisinin Derivatives Sales by Region (2027-2032)
  5. 6.3 Global Artemisinin Derivatives Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Artemisinin Derivatives Sales Value by Region (2021-2032)
  7. 6.4.1 Global Artemisinin Derivatives Sales Value by Region: 2021-2026
  8. 6.4.2 Global Artemisinin Derivatives Sales Value by Region (2027-2032)
  9. 6.5 Global Artemisinin Derivatives Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Artemisinin Derivatives Sales Value (2021-2032)
  12. 6.6.2 North America Artemisinin Derivatives Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Artemisinin Derivatives Sales Value (2021-2032)
  15. 6.7.2 Europe Artemisinin Derivatives Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Artemisinin Derivatives Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Artemisinin Derivatives Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Artemisinin Derivatives Sales Value (2021-2032)
  21. 6.9.2 South America Artemisinin Derivatives Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Artemisinin Derivatives Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Artemisinin Derivatives Sales Value Share by Country, 2025 VS 2032
7 Artemisinin Derivatives Country-level Sales and Value Analysis
  1. 7.1 Global Artemisinin Derivatives Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artemisinin Derivatives Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Artemisinin Derivatives Sales by Country (2021-2032)
  4. 7.3.1 Global Artemisinin Derivatives Sales by Country (2021-2026)
  5. 7.3.2 Global Artemisinin Derivatives Sales by Country (2027-2032)
  6. 7.4 Global Artemisinin Derivatives Sales Value by Country (2021-2032)
  7. 7.4.1 Global Artemisinin Derivatives Sales Value by Country (2021-2026)
  8. 7.4.2 Global Artemisinin Derivatives Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Artemisinin Derivatives Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Artemisinin Derivatives Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Artemisinin Derivatives Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Kerui Nanhai Pharmaceutical
  2. 8.1.1 Kerui Nanhai Pharmaceutical Company Information
  3. 8.1.2 Kerui Nanhai Pharmaceutical Business Overview
  4. 8.1.3 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product Portfolio
  6. 8.1.5 Kerui Nanhai Pharmaceutical Recent Developments
  7. 8.2 Shanghai Natural Bio-engineering Co
  8. 8.2.1 Shanghai Natural Bio-engineering Co Company Information
  9. 8.2.2 Shanghai Natural Bio-engineering Co Business Overview
  10. 8.2.3 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product Portfolio
  12. 8.2.5 Shanghai Natural Bio-engineering Co Recent Developments
  13. 8.3 Shanghai Natural Bio-engineering
  14. 8.3.1 Shanghai Natural Bio-engineering Company Information
  15. 8.3.2 Shanghai Natural Bio-engineering Business Overview
  16. 8.3.3 Shanghai Natural Bio-engineering Artemisinin Derivatives Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Natural Bio-engineering Artemisinin Derivatives Product Portfolio
  18. 8.3.5 Shanghai Natural Bio-engineering Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Artemisinin Derivatives Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Artemisinin Derivatives Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Kunming Pharmaceutical
  26. 8.5.1 Kunming Pharmaceutical Company Information
  27. 8.5.2 Kunming Pharmaceutical Business Overview
  28. 8.5.3 Kunming Pharmaceutical Artemisinin Derivatives Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kunming Pharmaceutical Artemisinin Derivatives Product Portfolio
  30. 8.5.5 Kunming Pharmaceutical Recent Developments
  31. 8.6 Kerui Nanhai
  32. 8.6.1 Kerui Nanhai Company Information
  33. 8.6.2 Kerui Nanhai Business Overview
  34. 8.6.3 Kerui Nanhai Artemisinin Derivatives Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Kerui Nanhai Artemisinin Derivatives Product Portfolio
  36. 8.6.5 Kerui Nanhai Recent Developments
  37. 8.7 Guilin Pharmaceutical
  38. 8.7.1 Guilin Pharmaceutical Company Information
  39. 8.7.2 Guilin Pharmaceutical Business Overview
  40. 8.7.3 Guilin Pharmaceutical Artemisinin Derivatives Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Guilin Pharmaceutical Artemisinin Derivatives Product Portfolio
  42. 8.7.5 Guilin Pharmaceutical Recent Developments
  43. 8.8 Guangxi Xiancaotang Pharmaceutical
  44. 8.8.1 Guangxi Xiancaotang Pharmaceutical Company Information
  45. 8.8.2 Guangxi Xiancaotang Pharmaceutical Business Overview
  46. 8.8.3 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product Portfolio
  48. 8.8.5 Guangxi Xiancaotang Pharmaceutical Recent Developments
  49. 8.9 Guangxi Xiancaotang
  50. 8.9.1 Guangxi Xiancaotang Company Information
  51. 8.9.2 Guangxi Xiancaotang Business Overview
  52. 8.9.3 Guangxi Xiancaotang Artemisinin Derivatives Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Guangxi Xiancaotang Artemisinin Derivatives Product Portfolio
  54. 8.9.5 Guangxi Xiancaotang Recent Developments
  55. 8.10 Novanat Bioresource
  56. 8.10.1 Novanat Bioresource Company Information
  57. 8.10.2 Novanat Bioresource Business Overview
  58. 8.10.3 Novanat Bioresource Artemisinin Derivatives Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Novanat Bioresource Artemisinin Derivatives Product Portfolio
  60. 8.10.5 Novanat Bioresource Recent Developments
  61. 8.11 KPC Pharmaceuticals
  62. 8.11.1 KPC Pharmaceuticals Company Information
  63. 8.11.2 KPC Pharmaceuticals Business Overview
  64. 8.11.3 KPC Pharmaceuticals Artemisinin Derivatives Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 KPC Pharmaceuticals Artemisinin Derivatives Product Portfolio
  66. 8.11.5 KPC Pharmaceuticals Recent Developments
  67. 8.12 Botanical Extracts EPZ Ltd
  68. 8.12.1 Botanical Extracts EPZ Ltd Company Information
  69. 8.12.2 Botanical Extracts EPZ Ltd Business Overview
  70. 8.12.3 Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Botanical Extracts EPZ Ltd Artemisinin Derivatives Product Portfolio
  72. 8.12.5 Botanical Extracts EPZ Ltd Recent Developments
  73. 8.13 ArtemiFlow
  74. 8.13.1 ArtemiFlow Company Information
  75. 8.13.2 ArtemiFlow Business Overview
  76. 8.13.3 ArtemiFlow Artemisinin Derivatives Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 ArtemiFlow Artemisinin Derivatives Product Portfolio
  78. 8.13.5 ArtemiFlow Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Artemisinin Derivatives Value Chain Analysis
  2. 9.1.1 Artemisinin Derivatives Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Artemisinin Derivatives Sales Mode & Process
  6. 9.2 Artemisinin Derivatives Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Artemisinin Derivatives Distributors
  9. 9.2.3 Artemisinin Derivatives Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst